Most Read Articles
Jairia Dela Cruz, 5 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 19 hours ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.

Initiation of hs-troponin assay in ED leads to more positive results in patients with chest pain

23 Aug 2020
Early diagnosis of heart disease in women, now a possibility with the High Sensitive Troponin test

The introduction of high-sensitive (hs) troponin assay in the emergency department (ED) has resulted in an increased percentage of positive hs-troponin tests in patients with noncardiac chest pain, but the average number of diagnostic tests has dwindled in those with chest pain presenting to the ED, suggesting greater confidence of clinicians in their diagnosis, a study has found.

Analysis was carried out using data from 1,274 patients (standard, n=597, 46.9 percent; hs-troponin, n=677, 53.1 percent). An increase in the number of patients with non-ST-segment elevation myocardial infarction was observed (hs-troponin 14.9 percent vs 9.7 percent), while the proportion in unstable angina (1.5 percent to 4.0 percent) and other cardiac illnesses (8.1 percent to 11.7 percent) decreased.

The proportion of positive hs-troponin was higher (6.1 percent vs 2.0 percent) but that of noncardiac chest pain illnesses remained the same (67 percent). In addition, the average number of additional tests per person fell in both troponin positive (20 to 1.7 test per patients; p=0.02) and troponin-negative patients (3.1 to 2.8 tests per patient; p<0.0001).

This study evaluated the impact of the introduction of the hs-troponin assay on the discharge diagnoses and the number of diagnostic tests in patients presenting with chest pain in a real-life setting in an ED. The authors performed a retrospective chart review of patients presenting with chest pain to one of the largest hospitals in Switzerland and compared the standard troponin period (December 2009 to November 2010) with the hs-troponin period (December 2010 to December 2011).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 5 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 19 hours ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.